At bioMérieux, our legacy is rooted in diagnostic innovation. With every system, software solution, and advancement, we aim to equip clinical teams with tools to stay ahead, so they can better serve their patients. This same commitment to progress inspired the development of the updated FILMARRAY system.
The BIOFIRE® FILMARRAY® TORCH System is everything the BIOFIRE 2.0 System is, but so much more. The BIOFIRE TORCH system offers features and benefits that help support patient care. And for a limited time, you can receive the best value when you upgrade to BIOFIRE TORCH System.
Product availability varies by country. Consult your bioMérieux representative.
BMX.2.022707
©2026 bioMérieux, Inc. • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656 • www.biomerieux-usa.com
Lower Respiratory Tract Infection Solutions
Explore More Respiratory Topics
Ready to upgrade or simply want more information?
Fill out the form below and we'll get you started.
Pneumonia patients are frequently given empiric, broad-spectrum antimicrobial therapy while awaiting diagnostic results. This can lead to overuse of antimicrobials. Diagnostic solutions from bioMérieux provide fast pathogen detection and support effective antimicrobial therapy management.
Fast and comprehensive, the BIOFIRE RP2.1 Panel identifies 22 of the most common respiratory pathogens, including SARS-CoV-2, influenza, and respiratory syncytial virus. Rapid respiratory results may enable better-informed diagnosis, treatment, and patient management decisions.
US FDA cleared
BIOFIRE® Respiratory 2.1 (RP2.1) Panel
1 Test. 22 Targets. ~45 Minutes.
VIDAS® B•R•A•H•M•S PCTTM
Procalcitonin (PCT) is a biomarker in the blood that indicates the presence of possible bacterial infection. In patients with bacterial pneumonia, PCT levels are typically elevated in tandem with the severity of the illness. On the other hand, PCT levels do not tend to rise significantly with viral infections or noninfectious inflammation. This makes PCT an especially useful tool for diagnosing and targeting treatment for patients with lower respiratory tract infections.
VIDAS B•R•A•H•M•S PCT is an innovative assay that tests for PCT levels in just 20 minutes. By delivering accurate results quickly, it can be used to help determine the best diagnostic and treatment options for patients who present with lower respiratory tract infections. Importantly, VIDAS B•R•A•H•M•S PCT has been cleared by the FDA to aid in decision making on safe antibiotic discontinuation for patients with suspected or confirmed lower respiratory tract infection.
BIOFIRE® FILMARRAY® Pneumonia (PN) Panel
1 Test. 33 Targets. ~1 Hour.
Pneumonia patients are frequently over-treated with antibiotics because it is difficult to quickly identify the pathogen responsible for their symptoms. The BIOFIRE PN Panel delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
US FDA cleared
By clicking the button below, you have read and agree to the Privacy Policy and agree to receive emails from bioMérieux. You can unsubscribe at any time.
It's Time to Upgrade Your
BIOFIRE® FILMARRAY® 2.0 System
* Required Fields
Upper Respiratory Tract Infection Solution
Upper respiratory infections often present with symptoms like coughing, congestion, and headache, which can be caused by several different respiratory pathogens. That’s why syndromic testing from bioMérieux identifies a broad range of probable pathogens in one quick test.
VIDAS®
B•R•A•H•M•S PCTTM
~20 minutes.
Limited-Time Discount
You’re eligible for special pricing when you upgrade your current system.
Upgrade Terms
Discounted Extended Warranty
The first-year manufacturer’s warranty is included, and you’ll get special promotional pricing for the extended warranty.
99% Discount on Verification
Verification packages will facilitate a smooth transition to the new system.
Respiratory Testing with
BIOFIRE® SPOTFIRE®
When upgrading your FILMARRAY system, we will also provide the option to replace it with the newest analyzer in our molecular fleet, the SPOTFIRE System. This solution is built for rapid, near-patient respiratory testing.
Like the BIOFIRE® Respiratory 2.1 (RP2.1) Panel, the FDA-cleared and CLIA-waived SPOTFIRE Respiratory/Sore Throat (R/ST) Panels test for a broad grouping of pathogens associated with upper respiratory tract and sore throat infections. With a single swab, you can get answers in ~15 minutes.1
The SPOTFIRE System is:1
- Simple: It takes less than two minutes of hands-on time.
- Fast: The turnaround time is around 15 minutes.
- Comprehensive: It can identify from 5 to up to 15 targets.
The BIOFIRE TORCH
System offers:
Comprehensive Syndromic Testing Menu
BIOFIRE TORCH is fully compatible with all eight BIOFIRE panels.
Smaller footprint on the bench*
Like its predecessor, the BIOFIRE TORCH features a vertical modular architecture that reduces its bench footprint, helping labs optimize valuable workspace.
Greater throughput*
Its smaller footprint also provides up to six times the throughput per spare foot of bench space per 24-hour period, allowing you to keep up testing demand with the same diagnostic rigor.
No-Hassle Service
Exceptional service is part of the foundation that helps bioMérieux lead with compassion, going beyond industry standards to achieve our goal of making the world a healthier place. This commitment is what drives us to help make your transition to your new system as easy as possible. Our Field Application Specialist team will support you with on-site installation, verification, and training.
References:
1. BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel [package insert] Salt Lake City, UT: bioMérieux, Inc. 2024.
*as compared to the BIOFIRE 2.0 System